Even patients who had already used another GLP-1 medication saw better results with tirzepatide
Overall, the use of metformin as an adjunct treatment for AN, particularly in patients with underlying hyperglycemia, is supported in the literature, but further studies are needed to clarify dosing, duration of therapy, and patient populations that will benefit most from adding metformin to their treatment regimens
Sound practice treats recurring IV therapy like any other infusion-based protocol: define the indication, set measurable goals, monitor labs and symptoms, and reduce frequency if benefit plateaus or risks rise
6ac), which instead may reflect its association with JIP4 or other interactors, as reported earlier, supporting competitive binding of different clients 31,34